Metipranolol
From Wikipedia, the free encyclopedia
|
Metipranolol
|
|
| Systematic (IUPAC) name | |
| [4-[2-hydroxy-3-(1-methylethylamino) propoxy]- 2,3,6-trimethyl-phenyl] ethanoate | |
| Identifiers | |
| CAS number | |
| ATC code | S01 C07BA68 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C17H27NO4 |
| Mol. mass | 309.401 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Metipranolol hydrochloride (OptiPranolol) is a non-selective beta blocker used in eye drops to treat glaucoma.
|
|||||||||||
|
||||||||||||||||||||

